Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-03 Purchase |
2022-03-18 5:14 pm |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
2,364 | $15.25 | $36,048 | 2,271,781 (Indirect Direct) |
View |
| 2020-12-08 Purchase(A) |
2022-02-24 7:55 pm |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
200 | $21 | $4,200 | 200 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-09-08 5:04 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Pepe Jeffrey C. Interim CEO and GC |
0 | $0 | 427,750 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:38 pm |
N/A 2030-04-28 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
78,740 | $0 | 657,239 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 4:38 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
78,740 | $1.27 | 657,239 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:52 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:48 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:44 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Powell Andrew Kenneth William Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:39 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Koehler Maria Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:33 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | Islam Saqib Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:31 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-13 7:27 pm |
N/A 2032-06-09 |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
18,000 | $0 | 18,000 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:19 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
204,321 | $0 | 311,716 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:16 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
131,074 | $0 | 156,608 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:12 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
135,700 | $0 | 152,106 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:07 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Hunder Naomi Chief Medical Officer |
129,532 | $0 | 140,782 (Direct) |
View |
| 2022-05-02 Option Award |
2022-05-04 5:00 pm |
N/A 2032-05-01 |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
85,005 | $0 | 93,921 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:22 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Hawkinson Russ Sr. Vice President of Finance |
81,000 | $0 | 82,454 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:19 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Piazza Jonathan Chief Financial Officer |
121,500 | $0 | 135,784 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:18 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Hunder Naomi Chief Medical Officer |
121,500 | $0 | 121,500 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:17 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Shawver Laura Chief Executive Officer |
297,000 | $0 | 376,895 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:16 pm |
N/A 2032-01-31 |
Silverback Therapeutics Inc. | SBTX | Odegard Valerie President and CSO |
164,719 | $0 | 164,719 (Direct) |
View |
| 2021-12-13 Other |
2021-12-15 2:56 pm |
N/A N/A |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
2,174,179 | $0 | 2,269,417 (Indirect) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:14 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | Thompson Peter A. Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:10 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | ROOT JONATHAN D Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:08 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | Powell Andrew Kenneth William Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:06 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | Islam Saqib Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:04 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | HERSHBERG ROBERT Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-06-04 Option Award |
2021-09-21 5:03 pm |
N/A 2031-06-03 |
Silverback Therapeutics Inc. | SBTX | CAPPS VICKIE L Director |
15,000 | $0 | 15,000 (Direct) |
View |